Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment

Andrey S Bavykin1 Russian Academy of Medical Science Research Centre for Medical Genetics, Moscow, Russian FederationCorrespondence[email protected]

Alexandra A Korotaeva1 Russian Academy of Medical Science Research Centre for Medical Genetics, Moscow, Russian Federation

Stanislav V Poyarkov2 D.I. Ivanovsky Institute of Virology Russian Academy of Medical Sciences, Moscow, Russian Federation

Alexandr V Syrtsev1 Russian Academy of Medical Science Research Centre for Medical Genetics, Moscow, Russian Federation;3 N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences; Moscow, Russian Federation

Sergei A Tjulandin3 N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences; Moscow, Russian Federation

Alexandr V Karpukhin1 Russian Academy of Medical Science Research Centre for Medical Genetics, Moscow, Russian Federation

Pages 1333-1340 | Published online: 23 Sep 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SamimiGManorekGCastelRcDNA microarray-based identification of genes and pathways associated with oxaliplatin resistanceCancer Chemother Pharmacol200555111115378272
PubMed Web of Science ®Google Scholar
VolandCBordAPélerauxARepression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cellsMol Cancer Ther2006592149215716985047
PubMed Web of Science ®Google Scholar
MeynardDLe MorvanVBonnetJRobertJFunctional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicityOncol Rep2007751213122117390068
PubMed Web of Science ®Google Scholar
ArnouldSHennebelleICanalPBugatRGuichardSCellular determinants of oxaliplatin sensitivity in colon cancer cell linesEur J Cancer200339111211912504667
PubMed Web of Science ®Google Scholar
GiacchettiSPerpointBZidaniRPhase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancerJ Clin Oncol20001813614710623704
PubMed Web of Science ®Google Scholar
ArangoDWilsonAJShiQMolecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cellsBr J Cancer200491111931194615545975
PubMed Web of Science ®Google Scholar
GalliganLLongleyDBMcEwanMWilsonTRMcLaughlinKJohnstonPGChemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIPMol Cancer Ther20054122026203616373718
PubMed Web of Science ®Google Scholar
SeetharamRNSoodABasu-MallickAAugenlichtLHMariadasonJMGoelSOxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cellsAnticancer Res20103072531253820682979
PubMed Web of Science ®Google Scholar
CollerHAGrandoriCTamayoPExpression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesionProc Natl Acad Sci U S A20009773260326510737792
PubMed Web of Science ®Google Scholar
FeltsSJOwenBANguyenPTrepelJDonnerDBToftDOThe hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional propertiesJ Biol Chem200027553305331210652318
PubMed Web of Science ®Google Scholar
MasudaYThe role of mitochondrial chaperone tumor necrosis factor-associated protein 1 (TRAP1) in the regulation of apoptosisJournal of Health Science201157119
Google Scholar
SohnWJLeeJWParkDGChange in expression of Survivin caused by using oxaliplatin in HCT116 colon cancer cellsJ Korean Soc Coloproctol201026424625321152225
PubMedGoogle Scholar
ShirotaYStoehlmacherJBrabenderJERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapyJ Clin Oncol200119234298430411731512
PubMed Web of Science ®Google Scholar
HarradineKAKassnerMChowDFunctional genomics reveals diverse cellular processes that modulate tumor cell response to oxaliplatinMol Cancer Res20119217318221169384
PubMed Web of Science ®Google Scholar
FujieYYamamotoHNganCYOxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cellsJpn J Clin Oncol200535845346316024531
PubMed Web of Science ®Google Scholar
NganCYYamamotoHTakagiAOxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cellsCancer Sci200899112913917949450
PubMed Web of Science ®Google Scholar
KhanZKhanNVarmaAKOxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxelCurr Cancer Drug Targets201010766066920578991
PubMed Web of Science ®Google Scholar
OhBYLeeRAKimKHsiRNA targeting LIVIN decreases tumor in a xenograft model for colon cancerWorld J Gastroenterol201117202563257121633662
PubMed Web of Science ®Google Scholar
WangXXuJJuSNiHZhuJWangHLIVIN gene plays a role in drug resistance of colon cancer cellsClin Biochem2010437–865566020171199
PubMed Web of Science ®Google Scholar
CaiMWangGBTaoKXCaiCX[Inhibitory effect of multiple siRNA recombinant expression vector targeting simultaneously LIVIN and Survivin genes on human colon cancer cells proliferation.]Yao Xue Xue Bao2009447741746 Chinese19806913
PubMedGoogle Scholar
ZhangSDingFLuoAXIAP is highly expressed in esophageal cancer and its downregulation by RNAi sensitizes esophageal carcinoma cell lines to chemotherapeuticsCancer Biol Ther20076697398017611394
PubMed Web of Science ®Google Scholar
YanagieHHisaTOgataAImprovement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitroBiomed Pharmacother200963855356018571892
PubMed Web of Science ®Google Scholar
GillCDowlingCO’NeillAJWatsonRWEffects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferationMol Cancer200983919549337
PubMed Web of Science ®Google Scholar
YangDSongXZhangJTherapeutic potential of siRNA-mediated combined knockdown of the IAP genes (LIVIN, XIAP, and Survivin) on human bladder cancer T24 cellsActa Biochim Biophys Sin (Shanghai)201042213714420119625
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date